QQQ   268.25 (-1.19%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
QQQ   268.25 (-1.19%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
QQQ   268.25 (-1.19%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
QQQ   268.25 (-1.19%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
Log in

NASDAQ:BIOLBIOLASE Stock Price, Forecast & News

$0.44
+0.02 (+4.76 %)
(As of 08/10/2020 12:05 PM ET)
Add
Compare
Today's Range
$0.42
Now: $0.44
$0.45
50-Day Range
$0.39
MA: $0.45
$0.52
52-Week Range
$0.21
Now: $0.44
$1.65
Volume6.56 million shs
Average Volume12.11 million shs
Market Capitalization$22.16 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02
BIOLASE, Inc., a medical device company, develops, manufactures, markets, and sells laser systems in dentistry and medicine for patients and health care professionals in the worldwide. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; and diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company also markets, sells, and distributes dental imaging equipment comprising three-dimensional (3D) CAD/CAM intra-oral scanners and digital dentistry software. Its dental imaging products include 3Shape TRIOS intraoral scanners, digital impression systems, and software for taking 3D scans, which are used to design crowns, study models, surgical guides for implant placement, and event orthodontic and athletic appliances. In addition, the company manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces. It sells its products primarily to dentists in general practice through its field sales force and distributor network. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.
Read More
BIOLASE logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.53 out of 5 stars


Industry, Sector and Symbol

Industry Dental equipment & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BIOL
Previous SymbolNASDAQ:BLTI
CUSIPN/A
Phone949-361-1200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$37.80 million
Book Value$0.01 per share

Profitability

Net Income$-17,850,000.00

Miscellaneous

Employees190
Market Cap$22.16 million
Next Earnings Date8/13/2020 (Confirmed)
OptionableNot Optionable
$0.44
+0.02 (+4.76 %)
(As of 08/10/2020 12:05 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BIOL News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











BIOLASE (NASDAQ:BIOL) Frequently Asked Questions

How has BIOLASE's stock been impacted by COVID-19 (Coronavirus)?

BIOLASE's stock was trading at $0.58 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BIOL shares have decreased by 24.1% and is now trading at $0.4403.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of BIOLASE?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BIOLASE in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for BIOLASE
.

When is BIOLASE's next earnings date?

BIOLASE is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020.
View our earnings forecast for BIOLASE
.

How can I listen to BIOLASE's earnings call?

BIOLASE will be holding an earnings conference call on Thursday, August 13th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were BIOLASE's earnings last quarter?

BIOLASE Inc (NASDAQ:BIOL) issued its quarterly earnings results on Thursday, May, 7th. The medical technology company reported ($0.19) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.14) by $0.05. The medical technology company had revenue of $4.78 million for the quarter. BIOLASE had a negative net margin of 58.75% and a negative return on equity of 645.85%.
View BIOLASE's earnings history
.

When did BIOLASE's stock split? How did BIOLASE's stock split work?

BIOLASE's stock reverse split on the morning of Friday, May 11th 2018. The 1-5 reverse split was announced on Thursday, May 10th 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 10th 2018. An investor that had 100 shares of BIOLASE stock prior to the reverse split would have 20 shares after the split.

What price target have analysts set for BIOL?

1 brokers have issued 1-year price targets for BIOLASE's shares. Their forecasts range from $3.00 to $3.00. On average, they expect BIOLASE's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 581.4% from the stock's current price.
View analysts' price targets for BIOLASE
.

Has BIOLASE been receiving favorable news coverage?

Press coverage about BIOL stock has trended very positive on Monday, according to InfoTrie. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. BIOLASE earned a coverage optimism score of 3.2 on InfoTrie's scale. They also gave media stories about the medical technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future.
View the latest news about BIOLASE
.

Who are some of BIOLASE's key competitors?

What other stocks do shareholders of BIOLASE own?

Who are BIOLASE's key executives?

BIOLASE's management team includes the following people:
  • Mr. Todd A. Norbe, Pres, CEO & Director (Age 52)
  • Mr. John R. Beaver, Exec. VP & CFO (Age 58)
  • Mr. Richard R. Whipp, VP of Operations (Age 67)
  • Mr. William E. Brown Jr., VP of Bus. Devel. (Age 71)
  • Mr. Daniel Merkin, National Sales Director (Age 46)

What is BIOLASE's stock symbol?

BIOLASE trades on the NASDAQ under the ticker symbol "BIOL."

How do I buy shares of BIOLASE?

Shares of BIOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BIOLASE's stock price today?

One share of BIOL stock can currently be purchased for approximately $0.44.

How big of a company is BIOLASE?

BIOLASE has a market capitalization of $22.16 million and generates $37.80 million in revenue each year. The medical technology company earns $-17,850,000.00 in net income (profit) each year or ($0.77) on an earnings per share basis. BIOLASE employs 190 workers across the globe.

What is BIOLASE's official website?

The official website for BIOLASE is www.biolase.com.

How can I contact BIOLASE?

BIOLASE's mailing address is 4 Cromwell, Irvine CA, 92618. The medical technology company can be reached via phone at 949-361-1200 or via email at [email protected]

This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.